SOPHiA GENETICS expands AstraZeneca partnership for AI breast cancer research
Go back to SOPHiA GENETICS expands AstraZeneca partnership for AI breast cancer research| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 847,585 | |||||
| (NASDAQ: SOPH) | Delayed: 7.53 -0.04 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.57 | 52 Week High | $ | |||
| Open | $7.61 | 52 Week Low | $ | |||
| Day High | $7.61 | P/E | N/A | |||
| Day Low | $7.37 | EPS | $ | |||
| Volume | 170,394 | |||||

